20 articles
A sponsored 90-day trial of enhanced-absorption quercetin targeting cholesterol, blood sugar, and metabolic age was terminated before completion.
A completed trial investigates whether replenishing glutathione precursors can reverse metabolic dysfunction in elderly adults.
Phase 4 trial tests whether alirocumab can better control non-HDL cholesterol in high-risk type 2 diabetics failing statin therapy.
A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
Maastricht University investigated whether NA, NAM, and tryptophan together could restore mitochondrial function in physically compromised older adults.
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
Eli Lilly's phase 3 trial pits a novel weekly basal insulin against the gold-standard daily insulin degludec in type 1 diabetes patients.
A Phase 1 trial tests whether lowering compensatory hyperinsulinemia with diazoxide improves glucose and lipid metabolism in NAFLD patients.
UCSF study reveals how metformin and trimethoprim interfere with thiamine uptake, potentially affecting energy metabolism.
Small trial tests whether diabetes drug metformin can enhance immune response to flu vaccination in aging adults.
Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.
Small trial tested whether the diabetes drug metformin could enhance immune response to pneumonia vaccine in aging adults.
